Warning for substitute dispensing of non-bioequivalence drugs

In response to a question raised by a civil petitioner, the Health Insurance Review Agency (HIRA) said that the substitute dispensing should be in principle made available among the drugs having identical bioequivalence profiles. Under the HIRA's authoritative interpretation, it is required that a pharmacist shall not dispense any substitute drugs without consent of a physician, a dentist, an o...